Delivery Order SPE2DR25D1205-SPE2DR26F0YP7
- Not listed
- The Defense Logistics Agency awarded a $2,652.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Onfil 10 mg, with an ultimate completion date of October 20, 2025. This non-competitive delivery order was issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical supply vehicle valued through December 2026. The place of performance is AmerisourceBergen's...
- This delivery order, valued at $1,069.20, was awarded to AmerisourceBergen Drug Corp on October 4, 2025, by the Defense Logistics Agency's Medical Supply Chain division. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of October 6, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child order under a larger indefinite delivery contract vehicle, this delivery order represents one of numerous...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of Onfil 10 mg, valued at $1,783.02, with a firm fixed price structure and an ultimate completion date of December 15, 2025. This non-set-aside competitive award was issued on December 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action executed under a larger contract vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $41,007.96 to AmerisourceBergen Drug Corp on November 7, 2025, for pharmaceutical products and medical supplies under a Firm Fixed Price contract type. This non-set-aside delivery order, with an ultimate completion date of November 10, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical. The work will be performed at the contractor's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,150.72 to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Onfil 20 mg tablets (100-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation, scheduled for completion by September 29, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,783.04 to AmerisourceBergen Drug Corp on November 18, 2025, with completion scheduled for November 19, 2025. This firm fixed-price, non-competitive delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion and extending through December 2026. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,720.63 to AmerisourceBergen Drug Corp on November 7, 2025, under a firm fixed price, non-competitive contract structure. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Department's Medical Supply Chain awarded a delivery order valued at $10,218.17 to AmerisourceBergen Drug Corp on July 31, 2025, with an ultimate completion date of August 1, 2025. This firm fixed price, non-set-aside delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement valued through December 2026. The delivery order...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $17,849.85 to AmerisourceBergen Drug Corp on August 6, 2025, with an ultimate completion date of August 7, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $45,278.31 on July 28, 2025, by the Defense Logistics Agency's Medical Supply Chain with a completion date of July 29, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F0YP7Delivery Order
The Defense Logistics Agency awarded a $3,576.31 firm fixed price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Onfio 10 mg, with a completion date of December 19, 2025. This non-set-aside contract represents a routine pharmaceutical supply transaction executed through the company's existing indefinite delivery vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and maintains extensive contracts supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, and vaccines to support military healthcare programs globally. The company's demonstrated capability to compete successfully for federal pharmaceutical contracts, combined with its role as a primary vendor within DLA's Medical Supply Chain, positions it to serve federal healthcare customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 12/17/25 |